FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Daptomycin for Injection Recall

Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, R…

PFIZER · Lake Forest, IL

Risk level
Class II
Reported by FDA
Aug 8, 2018
Recall ID
D-1023-2018
Check your lot numberHow we source this data

Summary

Pfizer recalled Daptomycin for Injection starting Jun 28, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1023-2018 on Aug 8, 2018. Reason: Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination. Status: Terminated.

Why it was recalled

Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.

Product description

Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.

Lot numbers, UPCs & expiration codes

Lot #: 712453A, Exp 1-Nov-18; 771803A, Exp 1-May-19; 792103A, Exp 1-Jul-19; 800903A, Exp 1-Aug-19; 810853A, Exp 1-Sep-19; 841703A, 841753A, Exp 1-Dec-19; 850553A, Exp 1-Jan-20.

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1023-2018
Classification
Class II
Status
Terminated
Recall initiated
Jun 28, 2018
FDA report date
Aug 8, 2018
Quantity
234,680 vials
Recall type
Voluntary: Firm initiated
Recalling firm
PFIZER

Original FDA data

Every field from FDA enforcement report D-1023-2018, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
80399
Address
275 N Field Dr
Code information
Lot #: 712453A, Exp 1-Nov-18; 771803A, Exp 1-May-19; 792103A, Exp 1-Jul-19; 800903A, Exp 1-Aug-19; 810853A, Exp 1-Sep-19; 841703A, 841753A, Exp 1-Dec-19; 850553A, Exp 1-Jan-20.
Postal code
60045-2579
Report date
Aug 8, 2018
Product type
Drugs
Recall number
D-1023-2018
Classification
Class II
Recalling firm
PFIZER
Product quantity
234,680 vials
Termination date
Aug 25, 2022
Reason for recall
Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Jun 28, 2018
Initial firm notification
Press Release
Center classification date
Aug 2, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1023-2018, published Aug 8, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls